mdlinx mdlinx
Gastroenterology Articles on MDLinx
Latest (31) Full Text Top Read since last login Article Summary

Contributing Factors to Gastric Ulcer Healing After Endoscopic Submucosal Dissection Including the Promoting Effect of Rebamipide
Digestive Diseases and Sciences, 08/18/2011  Clinical Article

Kobayashi M et al. – Healing in endoscopic submucosal dissection(ESD)–induced ulcers was dependent on the initial ulcer size. In large–sized ulcers, rebamipide promotes basal healing.

Methods
  • 170 patients with early gastric cancers that had undergone ESD were enrolled.
  • Follow-up endoscopy was scheduled at 4–6 weeks after ESD.
  • The authors assessed marginal healing and basal healing independently by endoscopic observation.
  • Marginal healing was determined by a regenerating epithelium and/or converging folds around the periphery of the ulcer.
  • Basal healing was declared when the ulcer was covered by white coat thinning such that basal granulation could be seen.
  • Sizes of the artificial ulcers were divided into normal size (area <1,200 mm2) or large size (area ≥1,200 mm2).

Results
  • Initial ulcer size and duration after ESD were significantly correlated with both marginal and basal healing rates by univariate analysis.
  • Marginal healing rate of antral lesions was higher than that of body lesions.
  • Multivariate analysis showed a large-sized ulcer was the only significant predictor of delayed healing, with delayed healing defined as no observed marginal or basal healing (p< 0.0001).
  • Subgroup analysis for the effect of rebamipide on large-sized ulcers showed a significantly higher rate of basal healing in the combination PPI and rebamipide group (p=0.015).

Read this article in Digestive Diseases and Sciences read MDLinx article: Contributing Factors to Gastric Ulcer Healing After Endoscopic Submucosal Dissection Including the Promoting Effect of Rebamipide

<< Previous Article | Next Article >>
Showing Latest Articles
Get reports via email to claim your reading activity at MDLinx as Category 2 CME (It takes less than a minute)

Most Popular Gastroenterology Articles

Last month's top read Top 50 of 2011

1 Helicobacter pylori Infection: Sequential Therapy Followed by Levofloxacin-Containing Triple Therapy provides a Good Cumulative Eradication Rate Helicobacter, April 6, 2012    Clinical Article

2 Adalimumab in steroid-dependent Crohns disease patients: Prognostic factors for clinical benefit Inflammatory Bowel Disease, April 17, 2012    Clinical Article

3 Rifaximin-Extended Intestinal Release Induces Remission in Patients With Moderately Active Crohns Disease Gastroenterology, February 29, 2012    Clinical Article

4 Serrated Polyp Detection Rate During Screening Colonoscopy Colorectal Disease, March 14, 2012

5 High-dose rabeprazole-amoxicillin dual therapy and rabeprazole triple therapy with amoxicillin and levofloxacin for 2 weeks as first and second line rescue therapies for Helicobacter pylori treatment failures Alimentary Pharmacology and Therapeutics, March 12, 2012    Clinical Article

6 Natalizumab for moderate to severe Crohns disease in clinical practice Inflammatory Bowel Disease, April 3, 2012    Clinical Article

7 Prognosis of lymphoma in patients following treatment with 6-mercaptopurine/azathioprine for inflammatory bowel disease Inflammatory Bowel Disease, April 23, 2012    Clinical Article

8 Frequent Detection of Pancreatic Lesions in Asymptomatic High-Risk Individuals Gastroenterology, April 6, 2012

9 Randomized Comparison of Two Non-Bismuth-Containing Second-line Rescue Therapies for Helicobacter pylori Helicobacter, April 11, 2012    Clinical Article

10 Natalizumab for moderate to severe Crohns disease in clinical practice Inflammatory Bowel Disease, April 18, 2012    Clinical Article

11 Nonbismuth Quadruple (Concomitant) Therapy: Empirical and Tailored Efficacy versus Standard Triple Therapy for Clarithromycin-Susceptible Helicobacter pylori and versus Sequential Therapy for Clarithromycin-Resistant Strains Helicobacter, April 13, 2012    Clinical Article

12 Scheduled infliximab monotherapy to prevent recurrence of Crohns disease following ileocolic or ileal resection: A 3-year prospective randomized open trial Inflammatory Bowel Disease, April 20, 2012    Clinical Article

13 Trough levels and antibodies to infliximab may not predict response to intensification of infliximab therapy in patients with inflammatory bowel disease Inflammatory Bowel Disease, April 16, 2012    Clinical Article

14 Assessment of Helicobacter pylori Eradication by Virgin Olive Oil Helicobacter, April 24, 2012    Clinical Article

15 Twice-daily proton pump inhibitor therapy does not decrease the frequency of reflux episodes during nocturnal recumbency in patients with refractory GERD: analysis of 200 patients using multichannel intraluminal impedance-pH testing Diseases of the Esophagus, April 27, 2012    Clinical Article

16 Vaniprevir with peginterferon alfa-2a and ribavirin in treatment-naive patients with chronic hepatitis C - a randomized phase 2 study Hepatology, April 19, 2012    Clinical Article

17 Systematic review: antibodies and anti-TNF- levels in inflammatory bowel disease Alimentary Pharmacology and Therapeutics, April 12, 2012    Clinical Article

18 Once-daily versus multiple-daily mesalamine for patients with ulcerative colitis: a meta-analysis Journal of Digestive Diseases, March 27, 2012    Evidence Based Medicine    Clinical Article

19 Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial The Lancet Infectious Diseases, March 27, 2012    Clinical Article

20 The Association Between Barretts Esophagus and Helicobacter pylori Infection: A Meta-Analysis Helicobacter, April 3, 2012    Clinical Article

Indexed Journals in Gastroenterology: Gastroenterology, American Journal of Gastroenterology, Gutmore

Other Topics in Gastroenterology

Stay current - Media Tool

Newsletter
RSS
Follow Us
Facebook

Edit My Newsletter Settings

Receive free subspecialty
"5-minute updates" via email

Sign up!

Send the E-mail Newsletter to a Colleague


Send

Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More

Close